4//SEC Filing
BioXcel Holdings, Inc. 4
Accession 0001104659-21-086943
CIK 0001720893other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:21 PM ET
Size
5.9 KB
Accession
0001104659-21-086943
Insider Transaction Report
Form 4
BioXcel Holdings, Inc.
10% Owner
Transactions
- Sale
Common Stock
2021-06-25$30.83/sh−473,250$14,589,493→ 8,546,750 total(indirect: See footnotes)
Footnotes (2)
- [F1]On June 25, 2021, BioXcel LLC sold 473,250 shares of common stock of the Issuer as a selling stockholder in an underwritten public secondary offering at a price to the public of $31.70. The reported sale price reflects the price at which BioXcel LLC sold shares to the underwriters after underwriting discounts and commissions.
- [F2]These securities are held of record by BioXcel LLC. BioXcel LLC is a subsidiary of the Reporting Person. By virtue of these relationships, the Reporting Person may be deemed to be the beneficial owner of the securities held of record by BioXcel LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for the purpose of Section 16 or for any other purpose.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001811154
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:21 PM ET
- Size
- 5.9 KB